SavedAdd your journal

Journals / Journal of the Turkish Chemical Society Section A: Chemistry / 2021 / Cilt: 8 - Sayı: 2

Inhibitory effects of novel benzamide derivatives towards acetylcholinesterase enzyme

Cem YAMALI
Halise İnci GÜL
Serkan LEVENT
Yeliz DEMİR
Pages
429–434
Publication Date
2021-05-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Bioactivity results obtained by this study may provide useful information on the development of novel and potent inhibitors targeting Alzheimer's disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Alzheimer's disease is one of the diseases which is identified by progressive memory loss and cognitive deficits leading to a decline in the lifespan of the patients.
📊
Key Findings & Data:In this study, N-(4-(N-(diaminomethylene)sulfamoyl)phenyl)-2-(substituted-benzamido)benzamide derivatives were synthesized and evaluated towards acetylcholinesterase (AChE, E.C.3.1.1.7) enzyme which is the most studied enzyme regarding Alzheimer's disease.
💡
Conclusion & Impact:Bioactivity results obtained by this study may provide useful information on the development of novel and potent inhibitors targeting Alzheimer's disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Acetylcholinesterase · sulfaguanidine · Alzheimer's disease

Abstract

Alzheimer's disease is one of the diseases which is identified by progressive memory loss and cognitive deficits leading to a decline in the lifespan of the patients. The drugs used in the clinic show palliative properties and they are unable to modify disease progression. In this study, N-(4-(N-(diaminomethylene)sulfamoyl)phenyl)-2-(substituted-benzamido)benzamide derivatives were synthesized and evaluated towards acetylcholinesterase (AChE, E.C.3.1.1.7) enzyme which is the most studied enzyme regarding Alzheimer's disease. The inhibition constants (Ki) of the compounds synthesized towards the AChE enzyme were in the range of 15.51 ± 1.88 - 41.24 ± 10.13 nM. The most effective compound with the lowest Ki = 15.51 ± 1.88 nM, 2-benzamido-N-(4-(N-(diaminomethylene)sulfamoyl)phenyl)benzamide 6, can be reported as a lead compound of this study. Bioactivity results obtained by this study may provide useful information on the development of novel and potent inhibitors targeting Alzheimer's disease.

🔖

Cite This Article

YAMALI, C., GÜL, H. İ., LEVENT, S., DEMİR, Y. (2021). Inhibitory effects of novel benzamide derivatives towards acetylcholinesterase enzyme. Journal of the Turkish Chemical Society Section A: Chemistry, Cilt: 8 - Sayı: 2, 429–434. https://ajindex.com/articles/781124

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Wajid S, Khatoon A, Khan MA, Zafar H, Kanwal S et al. Microwave-assisted organic synthesis, structure-activity relationship, kinetics and molecular docking studies of non-cytotoxic benzamide derivatives as selective butyrylcholinesterase inhibitors. Bioorganic and Medicinal Chemistry. 2019
  2. 27(18): 4030-40. doi: 10.1016/j.bmc.2019.07.015 2. Kratky M, Stepankova S, Vorcakova K, Svarcova M, Vinsova J. Novel cholinesterase inhibitors based on O-aromatic N,N-disubstituted carbamates and thiocarbamates. Molecules. 2016
  3. 21(2): 191-01. doi: 10.3390/molecules21020191 3. Oliveira C, Bagetta D, Cagide F, Teixeira J, Amorim R, Silva T, et al. Benzoic acid-derived nitrones: A new class of potential acetylcholinesterase inhibitors and neuroprotective agents. European Journal of Medicinal Chemistry. 2019
  4. doi: 10.1016/j.ejmech.2019.04.026 4. Peng DY, Sun Q, Zhu XL, Lin HY, Chen Q, Yu NX, et al. Design, synthesis, and bioevaluation of benzamides: novel acetylcholinesterase inhibitors with multi-functions on butylcholinesterase, A? aggregation, and ?-secretase. Bioorganic and Medicinal Chemistry. 2012
  5. 20(22):6739-50. doi: 10.1016/j.bmc.2012.09.016 5. https://www.nia.nih.gov/health/how-alzheimers-disease-treated, December 2020. 6. Darras FH, Kling B, Sawatzky E, Heilmann J, Decker M. Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase. Bioorganic and Medicinal Chemistry. 2014
  6. 22(17):5020-34. doi: 10.1016/j.bmc.2014.06.010 7. Yiannopoulou KG, Papageorgiou SG. Current and future treatments for Alzheimer's disease. Therapeutic Advances in Neurological Disorders. 2013
  7. 6(1):19-33. doi: 10.1177/1756285612461679 8. Sekutor M, Mlinaric-Majerski K, Hrenar T, Tomic S, Primozic I. Adamantane-substituted guanylhydrazones: novel inhibitors of butyrylcholinesterase. Bioorganic Chemistry. 2012
  8. doi: 10.1016/j.bioorg.2012.01.004 9. Gul HI, Yamali C, Bulbuller M, Kirmizibayrak PB, Gul M, Angeli A, et al. Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes. Bioorganic Chemistry. 2018
  9. doi: 10.1016/j.bioorg.2018.03.027 10. Gul HI, Yamali C, Sakagami H, Angeli A, Leitans J, Kazaks A, et al. New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors. Bioorganic Chemistry. 2018
  10. doi: 10.1016/j.bioorg